Can diabetes be reversed?

Image
IANS New York
Last Updated : Jun 06 2014 | 3:35 PM IST

In a ray of hope for diabetes patients, scientists have discovered the cellular sequence that leads to the trigger of the disease.

They also found potential molecular targets for preventing or reversing the process.

"We have described the etiology of obesity-related diabetes. We have pinpointed the steps, the way the whole thing happens," said Jerrold M. Olefsky, a distinguished professor of medicine at University of California, San Diego.

"The research on mice suggests that the processes are comparable in humans and these findings are important to not just understanding how diabetes begins, but how better to treat and prevent it," he added.

During the study, the researchers fed mice a high-fat diet.

They observed that the abundant saturated fatty acids in the diet activated adenine nucleotide translocase 2 (ANT2) - a mitochondrial protein in fat cell membranes that is involved in cellular energy metabolism.

Activation of ANT2 caused increased oxygen consumption, which meant less was available for the rest of the cell.

The result was a relative state of hypoxia or inadequate oxygen supply.

It subsequently induced production of a protective transcription factor in fat cells called HIF-1alpha.

In turn, HIF-1alpha triggered release of chemokines, proteins that signal cellular distress, launching the immune system's inflammatory response.

A sustained high-fat diet ensured that the process continued unabated, leading to obesity, chronic low-grade tissue inflammation and eventually, insulin resistance in the mice.

The elucidation of this sequence also revealed two potential therapeutic targets: ANT2 and HIF-1alpha.

The researchers suggest that inhibiting either could blunt, or even reverse, the damaging cellular sequence.

Diabetes is characterised by high blood sugar levels poorly regulated by either inadequate insulin production or because cells to not respond properly to the regulating hormone.

The findings were published in the journal Cell.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 06 2014 | 3:30 PM IST

Next Story